期刊文献+

养心汤联合常规西药治疗心气虚弱型冠心病不稳定性心绞痛临床研究 被引量:7

Clinical Study on Yangxin Tang Combined with Conventional Western Medicine Therapy for Unstable Angina of Coronary Heart Disease of Heart Qi Weakness Type
下载PDF
导出
摘要 目的:观察养心汤联合常规西药治疗心气虚弱型冠心病不稳定性心绞痛的临床疗效。方法:选取75例心气虚弱型冠心病不稳定性心绞痛患者为研究对象,按随机数字表法分为治疗组40例与对照组35例。对照组给予常规西药治疗,治疗组在常规西药基础上加用养心汤,2组均连续治疗4周。对比2组治疗前后血脂指标、中医症状评分、心电图的变化。结果:治疗前,2组甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)及低密度脂蛋白胆固醇(LDL-C)水平比较,差异均无统计学意义(P> 0.05)。治疗后,2组TG、TC、LDL-C水平均较治疗前降低(P <0.05),HDL-C水平均较治疗前上升(P <0.05);治疗组TG、TC、LDL-C水平均低于对照组(P <0.05),HDL-C水平高于对照组(P <0.05)。治疗前,2组心胸隐痛、心悸气短、失眠、易汗、乏力、倦怠懒言评分比较,差异均无统计学意义(P> 0.05)。治疗后,2组6项中医症状评分均较治疗前降低(P <0.05),治疗组6项中医症状评分均低于对照组(P <0.05)。治疗组心电图疗效总有效率97.50%,对照组心电图疗效总有效率77.14%,2组比较,差异有统计学意义(P <0.05)。结论:养心汤联合常规西药治疗心气虚弱型冠心病不稳定性心绞痛,可有效调节患者的血脂,改善临床症状,提高治疗效果。 Objective:To observe the clinical effect of Yangxin tang combined with conventional western medicine therapy for unstable angina of coronary heart disease of heart qi weakness type. Methods:A total of 75 patients with unstable angina of coronary heart disease of heart qi weakness type were enrolled as study subjects,and were divided into the treatment group(40 cases) and the control group(35 cases) according to the random number table method. The control group was given conventional western medicine therapy, while the treatment group was additionally given Yangxin tang based on the conventional western medicine therapy. The continuous treatment in both groups lasted for four weeks. The changes of blood lipid index,Chinese medicine symptom score and electrocardiogram before and after treatment in the two groups were compared. Results:There was no significant difference being found in the comparisons of the levels of triglyceride(TG),total cholesterol(TC),high-density lipoprotein cholesterol(HDL-C) and low-density lipoprotein cholesterol(LDL-C) before treatment between the two groups(P > 0.05). After treatment,the levels of TG,TC and LDL-C in both groups were decreased when compared with those before treatment(P < 0.05),and the levels of HDL-C in both groups were increased when compared with those before treatment(P < 0.05);the levels of TG,TC and LDL-C in the treatment group were lower than those in the control group(P < 0.05),and the level of HDL-C in the treatment group was higher than that in the control group(P < 0.05).There was no significant difference being found in the comparison of the scores including dull pain in heart and chest,palpitation and shortness of breath,insomnia,easy to sweat,hypodynamia,burnout and dislike of talking before treatment between the two groups(P > 0.05). After treatment,six Chinese medicine symptom scores in both groups were decreased when compared with those before treatment(P < 0.05),and the six Chinese medicine symptom scores in the treatment group were lower than those in the control group(P < 0.05). The total effective rate of the curative effect of electrocardiogram was 97.5% in the treatment group and 77.14% in the control group,the difference being significant(P < 0.05). Conclusion:The therapy of Yangxin tang combined with conventional western medicine therapy for unstable angina of coronary heart disease of heart qi weakness type can effectively regulate the level of blood lipid of patients,improve clinical symptoms and enhance the clinical effect.
作者 柳小春 刘丽仙 林能明 LIU Xiaochun;LIU Lixian;LIN Nengming
出处 《新中医》 CAS 2019年第3期80-83,共4页 New Chinese Medicine
关键词 冠心病不稳定性心绞痛 心气虚弱 中西医结合疗法 养心汤 血脂 中医症状 心电图 Unstable angina of coronary heart disease Heart qi weakness Integrated Chinese and western medicine therapy Yangxin tang Blood lipid Chinese medicine symptom Electrocardiogram
  • 相关文献

参考文献6

二级参考文献47

  • 1李亚萍.三七总皂甙对心肌缺血再灌注的保护效应[J].中国医药导报,2005,2(17):72-73. 被引量:10
  • 2刘影哲,周亚滨,孙静,李杨.养心汤治疗冠心病不稳定性心绞痛临床观察[J].中医药学报,2009,37(4):40-41. 被引量:17
  • 3李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量:194
  • 4卢中莲,苏兰花.注射用血塞通(冻干)治疗脑梗死60例[J].广西中医药,2006,29(4):44-44. 被引量:1
  • 5郑筱萸.中药新药临床研究指导原则(试行)[M].北京:中国中医药科技出版社,2000.74.
  • 6Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 7Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 8Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 9CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 10Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.

共引文献2279

同被引文献74

引证文献7

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部